DOUTOR NICHIRES Holdings Co., Ltd.
Stock Price Chart
2026/08/21 UpdatedPrice Trend
2026/08/21 UpdatedPrice & Trading Details
2026/08/21 UpdatedPRICE
TRADING
Analyst Recommendations 1 analysts
Updated 2026/08/01Earnings Calendar
Updated 2026/08/01Recent Earnings
| Date | EPS Est. | EPS Actual | Surprise |
|---|---|---|---|
| 2024/01/11 | ¥36.30 | ¥30.56 | -15.8% |
| 2021/01/13 | ¥18.10 | ¥15.71 | -13.2% |
| 2020/01/13 | ¥29.40 | ¥32.52 | +10.6% |
| 2019/10/14 | ¥45.80 | ¥45.21 | -1.3% |
Shareholder Composition
Updated 2026/08/01Major Holders
Updated 2026/08/01| Institution | Ownership | Shares | Change |
|---|---|---|---|
|
VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund
|
389.1K | 0.00% | |
|
VANGUARD TAX-MANAGED FUNDS-Vanguard Developed Markets Index Fund
|
261.9K | +4.43% | |
|
iShares Trust-iShares Core MSCI EAFE ETF
|
213.2K | 0.00% | |
|
DFA INVESTMENT TRUST CO-The Japanese Small Company Series
|
151.7K | 0.00% | |
|
DFA INVESTMENT DIMENSIONS GROUP INC-Intl Core Eqy. 2 PORT.
|
136.6K | +9.10% | |
|
VANGUARD Intl Eqy. INDEX Fd.S-Vanguard FTSE All-World ex-US Small-Cap
|
104.2K | +2.06% |
Dividend History
Updated 2026/08/23| Year | Dividend | Change |
|---|---|---|
| 2026 | ¥30 | -44.4% |
| 2025 | ¥54 | +25.6% |
| 2024 | ¥43 | +19.4% |
| 2023 | ¥36 | +28.6% |
| 2022 | ¥28 | - |
Financial Performance
2026/08/23 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥109,363M | ¥126,864M | ¥140,625M | ¥148,822M |
| Gross Profit | ¥64,315M | ¥74,769M | ¥84,189M | ¥89,621M |
| Operating Income | -¥1,779M | ¥2,973M | ¥7,326M | ¥9,600M |
| Pretax Income | ¥3,441M | ¥4,040M | ¥7,466M | ¥9,330M |
| Net Income | ¥1,221M | ¥3,429M | ¥5,491M | ¥6,880M |
| EPS | ¥27.63 | ¥77.56 | ¥124.89 | ¥156.97 |
| Operating Margin | -1.63% | 2.34% | 5.21% | 6.45% |
| Balance Sheet | ||||
| Total Assets | ¥118,227M | ¥121,036M | ¥127,788M | ¥134,232M |
| Total Equity | ¥93,856M | ¥96,013M | ¥99,154M | ¥104,002M |
| Total Liabilities | ¥24,371M | ¥25,023M | ¥28,634M | ¥30,230M |
| Cash | ¥34,546M | ¥32,222M | ¥35,796M | ¥38,990M |
| Interest-bearing Debt | ¥1,539M | ¥1,708M | ¥2,395M | ¥2,112M |
| Equity Ratio | 79.39% | 79.33% | 77.59% | 77.48% |
| D/E Ratio | 0.02 | 0.02 | 0.02 | 0.02 |
| Cash Flow | ||||
| Operating CF | ¥14,637M | ¥5,171M | ¥11,795M | ¥12,351M |
| Investing CF | -¥4,933M | -¥5,588M | -¥4,904M | -¥6,231M |
| Financing CF | -¥1,503M | -¥1,982M | -¥3,373M | -¥2,933M |
| Free CF | ¥10,219M | -¥221M | ¥6,871M | ¥6,442M |
| Efficiency | ||||
| ROE | 1.30% | 3.57% | 5.54% | 6.62% |
| ROA | 1.03% | 2.83% | 4.30% | 5.13% |
Latest IR Information
-
First Quarter Results for FY2027 | Sales of ¥42.5 billion (YoY +8.2%)
Doutor Nedres Holdings Co., Ltd. achieved sales of ¥42.5 billion (YoY +8.2%) and net income of ¥2.7 billion (YoY +31.4%) in the first quarter of FY2027, maintaining strong performance. Segment-wise, both the coffee and restaurant businesses are expanding, reflecting robust...
Read more -
Completion of Share Buyback with Restricted Stock Compensation｜June 2026
The company has disposed of 52,100 shares of treasury stock with restricted stock compensation, with a payment amount of approximately 1.387 billion yen. The recipients are directors and directors of subsidiaries, and the completion date is June 26, 2026.
Read more -
[Dotoru-Nires] Share Buyback and Incentive System Implementation | May 2026
Dotoru-Nires will sell 52,100 common shares at 2,663 yen per share on June 26, 2026, as part of an incentive system for directors and affiliate officers.
Read more -
Fiscal Year Ending February 2026 Financial Summary [Japanese GAAP] (Consolidated)
For the fiscal year ending February 2026, net sales were 159.147 billion yen (6.9% YoY increase), operating income was 10.15 billion yen (5.8% YoY increase), and net income attributable to owners of parent was 7.234 billion yen (5.1% YoY increase).
Read more -
Notice Regarding Dividend of Surplus
Doutor Nippon Resort Holdings Co., Ltd. has decided on a year-end dividend of 30 yen per share with the record date of February 28, 2026, marking an increase of 1 yen from the previous forecast. The annual dividend is 57...
Read more
Latest News (5 items)
-
Average Analyst Rating: hold
Average Target Price: ¥3,300
Rating Score: 3.00 (Based on 1 analysts)
※1=Strong Buy, 5=Strong Sell
Company Information
About
DOUTOR NICHIRES Holdings Co., Ltd., together with its subsidiaries, operates and manages coffee shops and restaurants in Japan. It manufactures and sells breads and western-style confectionery; roasts, processes, and sells coffee; and imports, exports, purchases, and sells food products, as well as recruits and guides restaurant franchisees through a franchise chain system. The company is also involved in the manufacture and wholesale of confectionery products; management of bakery shops; wholesale of coffee machines, etc.; purchase and wholesale of fruits and vegetables; purchase, processing, and wholesale of meat products; manufacture of hams, sausages, and bacons; manufacture and wholesale of sauces and dressing products; and import of coffee beans and tea. In addition, it designs, constructs, maintains, and cleans stores; and operates natural food stores; produces hydroponic vegetables; distributes processed food; and engages in the logistic business, as well as offers online mail orders and delivery services. DOUTOR NICHIRES Holdings Co., Ltd. was incorporated in 2007 and is headquartered in Tokyo, Japan.
